Pharmacokinetics and Pharmacodynamics of Biological Drugs
Course, Master's level, 3FB037
Autumn 2024 Autumn 2024, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 4 December 2024–19 January 2025
- Language of instruction
- English
- Entry requirements
-
150 credits which of 120 credits in biomedicine, biology, pharmaceutical science, chemistry and/or science/engineering. Prior studies should contain 7.5 credits in pharmacokinetics and 7.5 credits in pharmacology. Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 15 April 2024
- Application code
- UU-39205
Admitted or on the waiting list?
- Registration period
- 26 November 2024–3 December 2024
- Information on registration from the department
About the course
The course provides a detailed picture of how different biological medicines are distributed and eliminated and how different target structures and disease states can affect their dose-concentration-effect relationship. Through lectures and workshops, the course sheds light on how the relationships affect both drug development and use, in comparison with more traditional drugs.
The course focuses on protein medicines and antibodies but also covers other types of biological medicines such as peptides, oligonucleotides, vaccines and cell therapies. We also discuss how knowledge about the dose-response relationships of biological medicines in preclinical studies is used to define clinical study design.
Reading list
No reading list found.